TrialDiabetologia2024

Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.

Liv Vernstrøm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.